← SEC 公告列表 | GOAI SEC 公告 | Eva Live Inc(GOAI)

重大事件 即時報告 8-K 2026-07-23

Eva Live 與機構投資者簽訂216萬美元可轉換票據協議,融資淨額約200萬美元

於 SEC 網站開啟原文

AI 繁中摘要

EVA LIVE INC.(股票代號:GOAI)於2026年7月21日與機構投資者Streeterville Capital, LLC簽訂證券購買協議,據此發行一筆本金總額216萬美元的有抵押可轉換票據(「初始票據」),以8%原始發行折讓計算,預計實收淨額約200萬美元。該票據年利率8%,期限24個月,並賦予投資者在交割後24個月內額外購買本金125萬美元的第二張票據(「額外票據」)的權利。交易預計在提交S-3表格的424(b)補充招股書後完成交割。 初始票據可轉換為公司普通股,轉換價定為轉換日前10個交易日每日成交量加權平均價(VWAP)最低值的87%,但設有0.472美元的底價。公司有權在提前10個交易日通知後,按110%的溢價贖回全部或部分未償餘額。若公司股價連續10個交易日低於底價,投資者有權每月強制贖回最高限額。若發生重大或輕微觸發事件(定義見票據),投資者可分別將未償餘額增加10%或5%(每類最多三次)。觸發事件未能在5個交易日內補救將構成違約,未償餘額立即到期,並按15%年利率計息。 為擔保該票據,公司與投資者另行簽訂擔保協議,授予其對公司全部或部分附屬公司股權、客戶賬戶、保險合約權利、設備及其他主要資產的擔保權益。 公司表示,募集所得資金將用於營運資金、一般企業用途及推進業務目標。對投資者而言,本次融資為公司帶來短期現金流,但轉換條款(87% VWAP折扣及底價機制)可能導致股權大幅稀釋,尤其若股價持續受壓;同時,抵押品設定及提前贖回條款亦增加財務靈活性與風險。投資者需密切留意後續轉換情況及股價表現。
展開英文正文
false
 0001983736
 
 
 
 
 
 
 
 0001983736
 
 
 2026-07-21
 2026-07-21
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

WASHINGTON,
DC 20549

 

FORM
8-K

 

CURRENT
REPORT

Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date
of Report

(Date
of earliest event reported): July 21, 2026

 

EVA
LIVE INC.

(Exact
name of registrant as specified in its charter)

 

 
 Nevada
  
 001-43076
  
 88-2864075

 
 (State
 or other jurisdiction

 of
 incorporation)

  
 (Commission

 File
 Number)

  
 (IRS.
 Employer

 Identification
 No.)

 
 

The
Plaza, 1800 Century Park East, Suite 600

Los
Angeles, CA 90067

(Address
of principal executive offices, including zip code)

 

(310)
229-5981

(Registrant’s
telephone number, including area code)

 

N/A

(Former
name or former address, if changed since the last report)

 

Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):

 

 
 ☐
 Written
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
  
  

 
 ☐
 Soliciting
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities
registered pursuant to Section 12(b) of the Act: None

 

 
 Title
 of each class
  
 Trading
 Symbol(s)
  
 Name
 of each exchange on which registered

 
 common
 stock, par value $0.0001
  
 GOAI
  
 The
 Nasdaq Stock Market LLC

 
 

Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging
growth company ☒

 

If
an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

  

 

 

Item
1.01 Entry into a Material Definitive Agreement.

 

On
July 21, 2026, Eva Live Inc (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”)
with Streeterville Capital, LLC, an accredited investor (the “Investor”). Pursuant to the Purchase Agreement, the Company
agreed to sell, and the Investor agreed to purchase, a secured convertible note of the Company, in the aggregate original principal amount
of $2,160,000 (the “Initial Note”), which is convertible into common stock of the Company. Pursuant to the Purchase Agreement
the Investor shall also have the right, for a period of 24 months after the Closing, to purchase one additional note with a principal
amount of $1,250,000.00 (the “Additional Note”). The transactions contemplated under the Purchase Agreement will close upon
satisfaction of the closing conditions including the filing of a Rule 424(b) prospectus supplement to the Company’s shelf registration
statement on Form S-3 registering the Conversion Shares, as defined in the Initial Note, that may be issued to the Investor upon conversion
of the Initial Note (“Closing”). Upon Closing, the Company will issue the Initial Note and receive gross proceeds of $2.0
million. The Company intends to use the net proceeds from the sale of the Initial Note for working capital requirements, general corporate
purposes, and the advancement of business objectives.

 

The
Initial Note

 

The
Initial Note will be issued at an original issue discount of eight percent (8%). The Initial Note bears interest at a rate of eight percent
(8%) per annum and will mature 24 months after the Closing. The Additional Note, if issued, will be issued with the same terms, provisions,
economics and collateral as the Initial Note.

 

The
Initial Note is convertible at the option of the Investor into common shares of the Company at a conversion rate equal to the Outstanding
Balance, as defined in the Initial Note, being converted divided by the Conversion Price, as defined in the Initial Note. The Conversion
Price is equal to 87% of the lowest daily VWAP for the ten (10) Trading Day period immediately preceding the applicable measurement date;
provided, however, that in no event will the Conversion Price be lower than the Floor Price, as defined in the Initial Note, which
is $0.472.

 

The
Company shall have the right to prepay the Outstanding Balance after providing 10 Trading Days’ prior written notice to the Investor.
If the Company exercises its right to prepay the Initial Note, the Company shall make payment to the Investor of an amount in cash equal
to 110% multiplied by the portion of the Outstanding Balance the Company elects to prepay.

 

Pursuant
to the Initial Note, in the event the Nasdaq Official Closing Price of the Company’s common shares is below the Floor Price for
ten (10) consecutive Trading Days, the Investor shall then have the right, exercisable at any time in its sole and absolute discretion,
to redeem up to the Maximum Monthly Redemption Amount, as defined in the Initial Note, per calendar month.

 

At
any time following the occurrence of a Major Trigger Event or Minor Trigger Event, each as defined in the Initial Note, the Investor
may, upon prior written notice to the Company, increase the Outstanding Balance of the Initial Note by 10% for each occurrence of any
Major Trigger Event and 5% for each occurrence of any Minor Trigger Event (the “Trigger Effect”), provided that the Trigger
Effect may only be applied three times with respect to Major Trigger Events and three times with respect to Minor Trigger Events and
the Trigger Effect does not apply to any Trigger Event pursuant to Section 4.1(j) of the Initial Note.

 

If
the Company fails to cure a Trigger Event, as defined in the Initial Note, within five trading days following the date of a written demand
notice by the Investor, the Trigger Event will automatically become an Event of Default, as defined in the initial Note. In Event of
Default has occurred, the Investor may accelerate the Initial Note by written notice to Borrower, with the Outstanding Balance becoming
immediately due and payable in cash at the Mandatory Default Amount, as defined in the Initial Note, and interest shall accrue on the
Outstanding Balance beginning on the date the applicable Event of Default occurred at an interest rate equal to fifteen percent (15%)
per annum.

 

  

  

 

 

This
initial Note is secured by the collateral set forth in the Security Agreement.

 

The
Security Agreement

 

In
connection with the Purchase Agreement and the Initial Note, at Closing the Company and the Investor will also enter into a security
agreement (the “Security Agreement”). Pursuant to the Security Agreement, the Company agreed to grant a security interest
in the Collateral, as defined in the Security Agreement. Such Collateral includes, among other assets, all equity interests in all wholly
or partially owned subsidiaries of the Company, all customer accounts, rights under insurance contracts, and rights relating to clients
underlying such insurance contracts, all goods and equipment now owned or hereafter acquired by the Company, etc.

 

The
foregoing does not purport to be a complete description of each of the Purchase Agreement, the Initial Note and the Security Agreement,
and is qualified in its entirety by reference to the full text of each of such document, which are filed as Exhibits 10.1, 4.1, and 10.2,
respectively, to this Form 8-K and incorporated herein by reference.

 

Item
2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off Balance Sheet Arrangement of a Registrant

 

The
description of the Initial Note issued by the Company described in Item 1.01 is incorporated herein.

 

Item
3.02 Unregistered Sales of Equity Securities.

 

The
description of the Initial Note and the Additional Note issued or to be issued by the Company described in Item 1.01 is incorporated
herein.

 

Item
8.01 Other Events.

 

The
issuance of the shares of Conversion Shares, as defined in the Initial Note, was registered pursuant to the Company’s shelf registration
statement on Form S-3 (File No. 333-294416), which was filed with the Securities and Exchange Commission (the “Commission”)
on March 18, 2026, and declared effective on March 24, 2026, and a prospectus supplement to the base prospectus forming a part of such
registration statement, which was filed by the Company with the Commission on July 23, 2026.

 

ITEM
9.01 - FINANCIAL STATEMENTS AND EXHIBITS.

 

Exhibits

 

 
 Exhibit
 No.
  
 Description

 
  
  
  

 
 4.1
  
 Form of Initial Note

 
 5.1
  
 Opinion of Sichenzia Ross Ference Carmel LLP

 
 10.1
  
 Securities
 Purchase Agreement, dated July 21, 2026

 
 10.2
  
 Form of Security Agreement

 
 104
  
 Cover
 Page Interactive Data File (embedded within the Inline XBRL document)

 
 

  

  

 

 

SIGNATURE

 

Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.

 

 
  
  
 EVA
 LIVE INC.

 
  
  
  
  

 
 July
 23, 2026
  
 By:
 /s/
 David Boulette

 
 Date
  
  
 David
 Boulette

 
  
  
  
 President
 and CEO